HITE Hedge Asset Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

HITE Hedge Asset Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-16,995	Closed	-$574K	–	176
2021 Q2	$574K	Sell	16,995 -12,584	-43%	-$321K	0.08%	120
2021 Q1	$692K	Buy	29,579 +8,199	+38%	+$248K	0.1%	126
2020 Q4	$616K	Buy	+21,380	New	+$538K	0.14%	98

HITE Hedge Asset Management's CNST Position: Q3 2021 in Review

HITE Hedge Asset Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 16,995 shares — an estimated $574K sold.

HITE Hedge Asset Management first reported a position in CNST in Q4 2020 and held it in 3 quarters. The position peaked at $692K in Q1 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

HITE Hedge Asset Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
HITE Hedge Asset Management sold 16,995 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $574K.
HITE Hedge Asset Management first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2020 and held it in 3 quarters.
HITE Hedge Asset Management's Constellation Pharmaceuticals, Inc. position peaked at $692K in Q1 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on HITE Hedge Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.